AstraZeneca
  1. Companies
  2. AstraZeneca
  3. Products
  4. Model AZD1390 Phase I - Glioblastoma

Model AZD1390 Phase I -Glioblastoma

SHARE

Mechanism: ATM inhibitor; Area under investigation: glioblastoma; Date commenced phase: Q2 2018; Estimated Filing Acceptance: US: EU: Japan: China. Additional information. Molecule size: Small molecule Status change.

Most popular related searches